zalcitabine has been researched along with squalene in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Couvreur, P; Desmaële, D; Gref, R | 1 |
| Andrieux, K; Argote, S; Bauduin, L; Bekkara-Aounallah, F; Caron, J; Clayette, P; Couvreur, P; Dereuddre-Bosquet, N; Desmaële, D; Gref, R; Hillaireau, H; Lepêtre, S; Rogez-Kreuz, C; Rousseau, B; Skanji, R; Yousfi, R | 1 |
| Ambike, A; Bekkara-Aounallah, F; Couvreur, P; Gref, R; Rosilio, V | 1 |
1 review(s) available for zalcitabine and squalene
| Article | Year |
|---|---|
Squalenoylation: a generic platform for nanoparticular drug delivery.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Deoxycytidine; Didanosine; Drug Delivery Systems; Gemcitabine; Humans; Nanoparticles; Squalene; Zalcitabine | 2012 |
2 other study(ies) available for zalcitabine and squalene
| Article | Year |
|---|---|
Anti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassemblies.
Topics: Adenosine Triphosphate; Animals; Anti-HIV Agents; Didanosine; Drug Resistance, Viral; Light; Nanoparticles; Nucleosides; Particle Size; Prodrugs; Rats; Rats, Wistar; Reverse Transcriptase Inhibitors; Scattering, Radiation; Squalene; Tissue Distribution; Treatment Outcome; Tritium; Zalcitabine | 2013 |
Interfacial behavior of PEGylated lipids and their effect on the stability of squalenoyl-drug nanoassemblies.
Topics: Adsorption; Cholesterol; Deoxycytidine; Drug Carriers; Drug Compounding; Drug Stability; Gemcitabine; Hydrophobic and Hydrophilic Interactions; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Polyethylene Glycols; Prodrugs; Squalene; Surface Tension; Zalcitabine | 2014 |